Company Profile
Future Positive Capital is a venture capital firm that invests in European companies leveraging advanced technologies to address universal challenges on a planetary scale, including climate change, biodiversity loss, healthcare access, and social equity. The firm targets seed and Series A stages with investments ranging from 500,000€ to 3 million€, emphasizing a holistic value creation model that integrates business viability, technological innovation, societal impact, and human capital. Drawing from the 'Future Cones' framework, they prioritize 'preferable futures' where positive outcomes compound across economic, environmental, and social dimensions, supporting entrepreneurs who redesign systems amid exponential global pressures like population aging and climate acceleration.
Established in 2019 and headquartered in Paris, France, Future Positive Capital launched its Future Positive Fund I, an early-stage venture capital fund with approximately $57.14 million in assets under management. The firm emerged at a historical tipping point where technological exponentials match the urgency of planetary challenges, inspired by trends like plummeting costs in solar, batteries, and DNA sequencing. Their investment thesis responds to converging macro trends—demographic shifts, regulatory changes, and corporate sustainability commitments—unlocking trillions in market opportunities at the intersection of technology and sustainability.
The firm's portfolio features 43 investments in innovative companies such as Aerones (wind farm robotics), Dendra Systems (ecosystem restoration), Sweetch Energy (renewable baseload from estuaries), Conceivable Life Sciences (IVF access), and Ouihelp (elderly care). Recent deals include aDryada (Series A, May 2025), Le Fourgon (Series A-II, January 2025), and participation in Aerones' $30 million round. These ventures span healthcare, renewable energy, biodiversity, and climate resilience, often covered in outlets like Reuters, TechCrunch, and CNBC.
Limited public details exist on the full team, but key members include Sofia Hmich and Alexandre Terrien, with managers bringing extensive experience in technology and healthcare sectors, having completed over 30 deals. The firm adopts a problems-first, operator mentality, providing collaborative support through board positions, ongoing dialogue, and impact monitoring via 'Positive Goals'—non-financial milestones tied to carried interest, ensuring alignment with sustainable objectives.
News & Signals (0)
No linked news activity found for this company.